265 related articles for article (PubMed ID: 32057323)
81. Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot study.
Benzidia I; Crichi B; Montlahuc C; Rafii H; N'Dour A; Sebuhyan M; Gauthier H; Ait Abdallah N; Benillouche P; Villiers S; Le Maignan C; Farge D
J Thromb Thrombolysis; 2022 Feb; 53(2):417-424. PubMed ID: 34296382
[TBL] [Abstract][Full Text] [Related]
82. Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology.
Verso M; Di Nisio M
Eur J Intern Med; 2020 Jan; 71():4-7. PubMed ID: 31732452
[TBL] [Abstract][Full Text] [Related]
83. What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients' Quality of Life?
Lloyd AJ; Dewilde S; Noble S; Reimer E; Lee AYY
Value Health; 2018 Apr; 21(4):449-455. PubMed ID: 29680102
[TBL] [Abstract][Full Text] [Related]
84. Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic.
Holmes CE; Ades S; Gilchrist S; Douce D; Libby K; Rogala B; Parenteau E; Cushman M; Holm AK
JCO Oncol Pract; 2020 Sep; 16(9):e868-e874. PubMed ID: 32267798
[TBL] [Abstract][Full Text] [Related]
85. [Thromboprophylaxis in ambulatory patients with cancer].
Hart C; Heudobler D; Linnemann B
Dtsch Med Wochenschr; 2020 Feb; 145(3):130-134. PubMed ID: 32018283
[TBL] [Abstract][Full Text] [Related]
86. Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery.
Cohen AT;
Thromb Haemost; 2010 Nov; 104(5):919-30. PubMed ID: 20941466
[TBL] [Abstract][Full Text] [Related]
87. Treatment of cancer-associated venous thromboembolism in patients under palliative care.
Debourdeau P; Sevestre MA; Bertoletti L; Mayeur D; Girard P; Scotté F; Sanchez O; Mahé I;
Arch Cardiovasc Dis; 2024 Jan; 117(1):94-100. PubMed ID: 38072741
[TBL] [Abstract][Full Text] [Related]
88. How to treat venous thromboembolism (TVE) in cancer patients: ten years of multidisciplinary team meetings (MDTM) at Saint-Louis Hospital.
Crichi B; Sebuhyan M; Abdallah NA; Montlahuc C; Bonnet C; Villiers S; Maignan CL; Yannoutsos A; Farge D
J Med Vasc; 2020 Nov; 45(6S):6S24-6S30. PubMed ID: 33276940
[TBL] [Abstract][Full Text] [Related]
89. Update on Guidelines for the Prevention of Cancer-Associated Thrombosis.
Elshoury A; Schaefer JK; Lim MY; Skalla DP; Streiff MB
J Natl Compr Canc Netw; 2022 Jun; 20(13):. PubMed ID: 35728777
[TBL] [Abstract][Full Text] [Related]
90. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
Al-Samkari H; Connors JM
Blood Adv; 2019 Nov; 3(22):3770-3779. PubMed ID: 31770442
[TBL] [Abstract][Full Text] [Related]
91. Drug-drug interaction (DDI) with direct oral anticoagulant (DOAC) in patients with cancer.
Sebuhyan M; Crichi B; Abdallah NA; Bonnet C; Deville L; Marjanovic Z; Farge D
J Med Vasc; 2020 Nov; 45(6S):6S31-6S38. PubMed ID: 33276942
[TBL] [Abstract][Full Text] [Related]
92. Recent developments and persisting challenges in the prevention and treatment of venous thromboembolism in patients with hematological malignancies.
Sorigue M; Cañamero E; Siguenza P; Nomdedeu M; López-Núñez JJ
Leuk Lymphoma; 2020 Jun; 61(6):1277-1291. PubMed ID: 31960713
[TBL] [Abstract][Full Text] [Related]
93. Impact of multidisciplinary team meetings on the management of venous thromboembolism. A clinical study of 142 cases.
Mauger C; Gouin I; Guéret P; Gac FN; Baillerie A; Lefeuvre C; Boutruche B; Bayard S; Jaquinandi V; Jégo P; Mahé G
J Med Vasc; 2020 Jul; 45(4):192-197. PubMed ID: 32571559
[TBL] [Abstract][Full Text] [Related]
94. [Prophylaxis and management of cancer-associated thrombosis: Practical issues about anticoagulant use].
Malka D; Girard N; Smadja DM; Chevreau C; Culine S; Lesur A; Rouzier R; Rozet F; Spano JP; Blay JY
Bull Cancer; 2023 Feb; 110(2):212-224. PubMed ID: 36494243
[TBL] [Abstract][Full Text] [Related]
95. Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist's impact on anticoagulant therapy.
Kandemir EA; Bayraktar-Ekincioglu A; Kilickap S
Support Care Cancer; 2021 Mar; 29(3):1699-1709. PubMed ID: 32776163
[TBL] [Abstract][Full Text] [Related]
96. Guidelines for treatment and prevention of venous thromboembolism among patients with cancer.
Kuderer NM; Lyman GH
Thromb Res; 2014 May; 133 Suppl 2(0 2):S122-7. PubMed ID: 24862132
[TBL] [Abstract][Full Text] [Related]
97. Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC).
Farge D; Cajfinger F; Falvo N; Berremili T; Couturaud F; Bensaoula O; Védrine L; Bensalha H; Bonnet I; Péré-Vergé D; Coudurier M; Li V; Rafii H; Benzidia I; Connors JM; Resche-Rigon M
Oncotarget; 2018 Jun; 9(43):26990-26999. PubMed ID: 29930745
[TBL] [Abstract][Full Text] [Related]
98. Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group.
Frenzel L; Decaux O; Macro M; Belhadj-Merzoug K; Manier S; Touzeau C; Leleu X; Frère C; Lecompte T; Perrot A; Avet-Loiseau H; Moreau P; Chalayer E
Thromb Res; 2024 Jan; 233():153-164. PubMed ID: 38064842
[TBL] [Abstract][Full Text] [Related]
99. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
Al-Samkari H; Connors JM
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):71-79. PubMed ID: 31808892
[TBL] [Abstract][Full Text] [Related]
100. European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism.
Patrice C; Ahmet F; Sylvia H; Elizabeth S; Carlos B; Frank C; Rupert B; Richard HFD
BMC Prim Care; 2024 Mar; 25(1):90. PubMed ID: 38500048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
